{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:00:03Z","timestamp":1792512003092,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,2,3]],"date-time":"2011-02-03T00:00:00Z","timestamp":1296691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Health Care and Philos"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s11019-011-9312-5","type":"journal-article","created":{"date-parts":[[2011,2,2]],"date-time":"2011-02-02T19:59:56Z","timestamp":1296676796000},"page":"61-77","source":"Crossref","is-referenced-by-count":13,"title":["How do medical device manufacturers\u2019 websites frame the value of health innovation? An empirical ethics analysis of five Canadian innovations"],"prefix":"10.1007","volume":"15","author":[{"given":"P.","family":"Lehoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hivon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Williams-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. R.","family":"Urbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,3]]},"reference":[{"key":"9312_CR1","first-page":"205","volume-title":"Managing technology in society: The approach of constructive technology assessment","author":"M Akrich","year":"1995","unstructured":"Akrich, M. 1995. User representations: Practices, methods and sociology. In Managing technology in society: The approach of constructive technology assessment, ed. A. Rip, T.J. Misa, and J. Schot, 205\u2013224. London: Pinter."},{"key":"9312_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11019-009-9223-x","volume":"13","author":"M Boenink","year":"2010","unstructured":"Boenink, M. 2010. Molecular medicine and concepts of disease: the ethical value of a conceptual analysis of emerging biomedical technologies. Medicine, Health Care and Philosophy 13: 11\u201323.","journal-title":"Medicine, Health Care and Philosophy"},{"key":"9312_CR3","volume-title":"De la justification. Les \u00e9conomies de la grandeur","author":"L Boltanski","year":"1991","unstructured":"Boltanski, L., and L. Th\u00e9venot. 1991. De la justification. Les \u00e9conomies de la grandeur. Paris: Gallimard."},{"key":"9312_CR4","first-page":"3","volume":"162","author":"N Brown","year":"2003","unstructured":"Brown, N. 2003. Hope against hype\u2014accountability in biopasts, presents and futures. Science Studies 162: 3\u201321.","journal-title":"Science Studies"},{"key":"9312_CR5","volume-title":"New medical technologies and society: Reordering life","author":"N Brown","year":"2004","unstructured":"Brown, N., and A. Webster. 2004. New medical technologies and society: Reordering life. Cambridge: Polity Press."},{"issue":"3","key":"9312_CR6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/icc\/11.3.529","volume":"11","author":"H Chesbrough","year":"2002","unstructured":"Chesbrough, H., and R.S. Rosenbloom. 2002. The role of the business model in capturing value from innovation: evidence from Xerox Corporation\u2019s technology spin-off companies. Industrial and Corporate Change 11(3): 529\u2013555.","journal-title":"Industrial and Corporate Change"},{"issue":"1\/2","key":"9312_CR7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1108\/03090560010306197","volume":"34","author":"L Chernatony de","year":"2000","unstructured":"de Chernatony, L., F. Harris, and F.D. Riley. 2000. Added value: its nature, roles and sustainability. European Journal of Marketing 34(1\/2): 39\u201356.","journal-title":"European Journal of Marketing"},{"key":"9312_CR8","doi-asserted-by":"crossref","unstructured":"Einsiedel, E.F. 2006. Introduction: Making sense of emerging technologies. In: First Impressions: Understanding Public Views on Emerging Technologies. GenomePrairie GE3LS Team, University of Calgary.","DOI":"10.59962\/9780774815505-003"},{"key":"9312_CR9","volume-title":"Strained mercy: The economics of Canadian health care","author":"B Evans","year":"1984","unstructured":"Evans, B. 1984. Strained mercy: The economics of Canadian health care. Toronto, Canada: Butterworths."},{"key":"9312_CR10","doi-asserted-by":"crossref","DOI":"10.1057\/9780230228368","volume-title":"Medical technology into healthcare and society: A sociology of devices, innovation and governance","author":"A Faulkner","year":"2008","unstructured":"Faulkner, A. 2008. Medical technology into healthcare and society: A sociology of devices, innovation and governance. Hampshire, UK: Palgrave Macmillan."},{"issue":"7","key":"9312_CR11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0277-9536(00)00389-0","volume":"53","author":"A Faulkner","year":"2001","unstructured":"Faulkner, A., and J. Kent. 2001. Innovation and regulation in human implant technologies: developing comparative approaches. Social Science and Medicine 53(7): 895\u2013913.","journal-title":"Social Science and Medicine"},{"key":"9312_CR12","doi-asserted-by":"crossref","unstructured":"Gagnon, M.-A. and J. Lexchin. 2008. The Cost of Pushing Pills: A new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med 5(1): e1. doi: 10.1371\/journal.pmed.0050001 .","DOI":"10.1371\/journal.pmed.0050001"},{"key":"9312_CR13","unstructured":"Gagnon, M.-A. 2009. The nature of capital in the knowledge-based economy: The case of the global pharmaceutical industry. York University: PhD in Political Science Dissertation."},{"key":"9312_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-8510(03)00100-3","volume":"67","author":"M Giacomini","year":"2004","unstructured":"Giacomini, M., J. Hurley, I. Gold, P. Smith, and J. Abelson. 2004. The policy analysis of value talk: Lessons from Canadian Health reform. Health Policy 67: 15\u201324.","journal-title":"Health Policy"},{"key":"9312_CR15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10202-003-0050-5","volume":"2","author":"A Grunwald","year":"2004","unstructured":"Grunwald, A. 2004. The normative basis of health technology assessment and the role of ethical expertise. Poiesis & Praxis 2: 175\u2013194.","journal-title":"Poiesis & Praxis"},{"issue":"2","key":"9312_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1467-8519.00273","volume":"16","author":"E Haimes","year":"2002","unstructured":"Haimes, E. 2002. What can the social sciences contribute to the study of ethics? Theoretical, empirical and substantive considerations. Bioethics 16(2): 89\u2013113.","journal-title":"Bioethics"},{"key":"9312_CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1024814710487","volume":"24","author":"M H\u00e4yry","year":"2003","unstructured":"H\u00e4yry, M. 2003. European values in bioethics: Why, what, and how to be used? Theoretical Medicine 24: 199\u2013214.","journal-title":"Theoretical Medicine"},{"issue":"8","key":"9312_CR18","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.socscimed.2010.01.005","volume":"70","author":"E Hemminki","year":"2010","unstructured":"Hemminki, E., H.K. Toiviainen, and L. Vuorenkoski. 2010. Co-operation between patient organisations and the drug industry in Finland. Social Science and Medicine 70(8): 1171\u20131175.","journal-title":"Social Science and Medicine"},{"key":"9312_CR19","doi-asserted-by":"crossref","DOI":"10.1515\/9781400837311","volume-title":"Design on Nature: Science and Democracy in Europe and the United States","author":"S Jasanoff","year":"2005","unstructured":"Jasanoff, S. 2005. Design on Nature: Science and Democracy in Europe and the United States. Princeton, NJ: Princeton University Press."},{"issue":"3","key":"9312_CR20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1377\/hlthaff.27.3.693","volume":"27","author":"CC Lake","year":"2008","unstructured":"Lake, C.C., R.A. Crittendon, and D. Mermin. 2008. Health care in the 2008 election: Engaging the voters. Health Affairs 27(3): 693\u2013708.","journal-title":"Health Affairs"},{"key":"9312_CR21","volume-title":"The problem of health technology","author":"P Lehoux","year":"2006","unstructured":"Lehoux, P. 2006. The problem of health technology. Policy implications for modern health care systems. New York: Routledge."},{"issue":"1","key":"9312_CR22","first-page":"1","volume":"32","author":"P Lehoux","year":"2009","unstructured":"Lehoux, P., J.-L. Denis, M. Rock, S. Tailliez, and M. Hivon. 2009. How do medical specialists appraise three controversial health innovations? Scientific, clinical and social arguments. Sociology of Health & Illness 32(1): 1\u201317.","journal-title":"Sociology of Health & Illness"},{"issue":"2\u20133","key":"9312_CR23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1215\/03616878-28-2-3-473","volume":"2","author":"DW Light","year":"2003","unstructured":"Light, D.W., R. Castellblanch, P. Arredondo, and D. Socolar. 2003. No exit and the organization of voice in biotechnology and pharmaceuticals. Journal of Health Politics, Policy and Law 2(2\u20133): 473\u2013507.","journal-title":"Journal of Health Politics, Policy and Law"},{"key":"9312_CR24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1023\/A:1025390030467","volume":"11","author":"AC Molewijk","year":"2004","unstructured":"Molewijk, A.C., A.M. Stiggelbout, W. Otten, H.M. Dupuis, and J. Kievit. 2004. Implicit normativity in evidence-based medicine: A plea for integrated empirical ethics research. Health Care Analysis 11: 69\u201392.","journal-title":"Health Care Analysis"},{"key":"9312_CR25","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/0003-4975(95)00802-R","volume":"60","author":"GD Nelson","year":"1995","unstructured":"Nelson, G.D. 1995. Medical device industry efforts to increase healthcare value. The Annals of Thoracic Surgery 60: 1534\u20131536.","journal-title":"The Annals of Thoracic Surgery"},{"key":"9312_CR26","volume-title":"Designing Interactive Strategy: From Value Chain to Value Constellation","author":"R Normann","year":"1994","unstructured":"Normann, R., and R. Ramirez. 1994. Designing Interactive Strategy: From Value Chain to Value Constellation. Chichester: John Wiley & Sons."},{"key":"9312_CR27","volume-title":"Competitive Strategy","author":"M Porter","year":"1985","unstructured":"Porter, M. 1985. Competitive Strategy. Techniques for Analysing Industries and Competitors. New York: The Free Press."},{"issue":"1","key":"9312_CR28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1377\/hlthaff.11.1.84","volume":"11","author":"R Priester","year":"1992","unstructured":"Priester, R. 1992. A values framework for health system reform. Health Affairs 11(1): 84\u2013107.","journal-title":"Health Affairs"},{"key":"9312_CR29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/(SICI)1097-0266(199901)20:1<49::AID-SMJ20>3.0.CO;2-2","volume":"20","author":"R Ramirez","year":"1999","unstructured":"Ramirez, R. 1999. Value co-production: intellectual origins and implications for practice and research. Strategic Management Journal 20: 49\u201365.","journal-title":"Strategic Management Journal"},{"key":"9312_CR30","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.socscimed.2009.10.066","volume":"70","author":"PM Saukko","year":"2010","unstructured":"Saukko, P.M., M. Reed, N. Britten, and S. Hogarth. 2010. Negotiating the boundary between medicine and consumer culture: Online marketing of nutrigenetic tests. Social Science and Medicine 70: 744\u2013753.","journal-title":"Social Science and Medicine"},{"issue":"2","key":"9312_CR31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1471-8847.2009.00256.x","volume":"10","author":"E Smith","year":"2010","unstructured":"Smith, E., C. Martin, J. Behrmann, and B. Williams-Jones. 2010. Reproductive tourism in Argentina: accreditation and its implications for consumers and policy makers. Developing World Bioethics 10(2): 59\u201369. (Published Online First: June 8 2009).","journal-title":"Developing World Bioethics"},{"key":"9312_CR32","volume-title":"Basics of Qualitative Research","author":"A Strauss","year":"1990","unstructured":"Strauss, A., and J. Corbin. 1990. Basics of Qualitative Research. Newbury Park: Sage."},{"issue":"6","key":"9312_CR33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1370\/afm.408","volume":"3","author":"SM Teutsch","year":"2005","unstructured":"Teutsch, S.M., and M.L. Berger. 2005. Misaligned incentives in Americas health: Who\u2019s minding the store? Annals of Family Medicine 3(6): 485\u2013487.","journal-title":"Annals of Family Medicine"},{"key":"9312_CR34","volume-title":"The Human Factor: Revolutionizing the Way People Live with Technology","author":"K Vicente","year":"2004","unstructured":"Vicente, K. 2004. The Human Factor: Revolutionizing the Way People Live with Technology. New York: Routledge."},{"key":"9312_CR35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00129785-200303060-00004","volume":"36","author":"B Williams-Jones","year":"2003","unstructured":"Williams-Jones, B., and O.P. Corrigan. 2003. Rhetoric and hype: Where\u2019s the \u201cEthics\u201d in pharmacogenomics? American Journal of Pharmacogenomics 36: 375\u2013383.","journal-title":"American Journal of Pharmacogenomics"},{"issue":"1","key":"9312_CR36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/14636770600603527","volume":"25","author":"B Williams-Jones","year":"2006","unstructured":"Williams-Jones, B. 2006. Be ready against cancer, now: Direct-to-consumer advertising for genetic testing. New Genetics and Society 25(1): 89\u2013107.","journal-title":"New Genetics and Society"},{"issue":"6","key":"9312_CR37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1370\/afm.406","volume":"3","author":"SH Woolf","year":"2005","unstructured":"Woolf, S.H., and R.E. Johnson. 2005. The break-even point: When medical advances are less important than improving the fidelity with which they are delivered. Annals of Family Medicine 3(6): 545\u2013552.","journal-title":"Annals of Family Medicine"}],"container-title":["Medicine, Health Care and Philosophy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11019-011-9312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11019-011-9312-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11019-011-9312-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:58:00Z","timestamp":1712174280000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11019-011-9312-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,3]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["9312"],"URL":"https:\/\/doi.org\/10.1007\/s11019-011-9312-5","relation":{},"ISSN":["1386-7423","1572-8633"],"issn-type":[{"value":"1386-7423","type":"print"},{"value":"1572-8633","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,3]]}}}